NLRP3 and acute respiratory distress syndrome: Since inactivation of NLRP3 inflammasome has been shown to protect against hyperoxia-induced ALI (Fukumoto et al., 2013), NLRP3 inflammasome may be a viable target for developing potential candidate drugs to treat ALI.